Genesis Energy Shares Slide 3.8% as Capital Raise Complete

Genesis Energy shares (ASX:GNE) closed 3.77% lower at A$1.78 on the ASX today as the New Zealand electricity generator and retailer completed its NZ$400 million equity raising, with new shares from both a placement and rights offer now settling into the market at prices well below recent trading levels.

The Genesis share price decline reflects the technical adjustment as Genesis finalises a fully underwritten 1-for-7.9 renounceable rights offer that priced at NZ$2.05 per share, translating to A$1.73 for Australian investors. The rights offer, which closed on 17 March 2026, follows a NZ$100 million institutional placement completed in late February at NZ$2.15 per share.

New shares from the rights offer are expected to settle and commence trading on 24 March 2026 on the ASX and 25 March 2026 on the NZX, adding significant supply to the register. Today’s closing price of A$1.78 sits just above the A$1.73 rights price, indicating the market is still digesting the dilutive impact of the capital raising despite strong underlying earnings momentum.

Details of the Capital Raise

Genesis successfully raised an aggregate NZ$400 million across the two tranches, with the proceeds earmarked to accelerate the company’s Gen35 growth strategy focused on renewable generation and dispatchable firming capacity. The shortfall bookbuild from the rights offer cleared at NZ$2.22 per share, delivering a NZ$0.17 premium above the NZ$2.05 application price and signalling robust institutional demand for the stock. Under the structure of the offer, eligible shareholders who did not take up their full entitlement, as well as ineligible shareholders, will receive the NZ$0.17 premium per unexercised right, with payments expected by 31 March 2026.

The New Zealand Crown, which maintains a 51% stake in Genesis, committed to fully participate in the rights offer to preserve its controlling interest. The new shares will rank equally with existing Genesis ordinary shares but are not entitled to the interim dividend of 7.30 cents per share paid on 25 March 2026, with a record date of 26 February 2026.

Fundamentals Underpin Investment

The capital raise was announced alongside Genesis’s interim result for the first half of FY26, which showed record normalised EBITDAF of NZ$307 million, up 38% from NZ$222 million in the prior corresponding period. Net profit after tax rose 36% to NZ$95 million, while gross margin climbed 27% to NZ$521 million. The company attributed the strong performance to its diversified portfolio of thermal and renewable generation assets, favourable hydro conditions, and generation flexibility that enabled it to manage its gas position and support system security heading into winter 2026.

For the full year ended 30 June 2025, Genesis reported revenue of approximately NZ$3.7 billion. The company continues to operate as one of New Zealand’s largest energy retailers, serving around 500,000 customers, and holds a 46% interest in the Kupe Oil & Gas Joint Venture.

Operating free cash flow for the half-year was negative NZ$183 million, compared with negative NZ$46 million in the prior period, reflecting increased capital expenditure and working capital movements associated with the accelerated investment programme. The negative cash flow underscores the rationale for the equity raise, as Genesis seeks to fund its growth pipeline without over-leveraging the balance sheet.

What Comes Next?

The NZ$400 million injection positions Genesis to execute on its Gen35 strategy, which aims to expand renewable generation capacity and add flexible, dispatchable assets to firm up the New Zealand electricity system as intermittent wind and solar capacity grows across the sector. The company’s ability to clear the shortfall bookbuild at a premium suggests markets view the growth investments as value-accretive, despite the near-term dilution.

However, the capital raise also highlights the capital intensity of Genesis’s transition pathway and the execution risk inherent in large-scale infrastructure projects, particularly in an environment of elevated construction costs and regulatory scrutiny. The company will need to demonstrate that the new investments generate returns above its cost of equity to justify the dilution and support a valuation re-rating.